Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...

Atria Investments Inc cut its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 34.4% in the fourth ...

DES LACS, N.D.– The Des Lacs Burlington Lakers have punched their ticket into the state tournament this season, after coming away with their 3rd straight Region Title. The DLB Lakers enter ...

A recent study provided key insights into brain degeneration in DLB, which may help clinicians better monitor this ...

Highlights,Institutional investors have adjusted their holdings in Dolby Laboratories, reflecting continued interest in the electronics sector.,Recent filings show increased positions from multiple ...

Roth MKM raised the firm’s price target on CervoMed (CRVO) to $20 from $15 and keeps a Buy rating on the shares. The firm is positive on the ...

Highlights,Institutional investors have recently adjusted their positions in Dolby Laboratories, reflecting changes in market ...

Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy bodies (DLB), ...

We recently published a list of These 10 Stocks Posted Double-, Triple-Digit Gains Last Week. In this article, we are going ...

JonesResearch upgraded CervoMed (CRVO) to Buy from Hold with a $15 price target arguing that the company’s latest data from ...

Arista Networks Inc., which is the network vendor that has done the most effective job of tying its growth to AI, Wednesday announced new capabilities for its EOS Smart AI Suite designed to improve AI ...

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and ...